Co-Expression of Programmed Death-Ligand 1 (PD-L1) Expression in EGFR Mutant Stage IV Lung Adenocarcinoma

被引：0
|
作者：
Hsu, P. [1 ]
Wang, C. [2 ]
Kuo, S. [3 ]
Yang, C. [4 ]
机构：
[1] Chang Gung Med Fdn, Taoyuan, Taoyuan County, Taiwan
[2] Chang Gung Med Fdn, Dept Pathol, Taoyuan, Taoyuan County, Taiwan
[3] Chang Gung Med Fdn, Dept Thorac Med, Taoyuan, Taoyuan County, Taiwan
[4] Chang Gung Mem Hosp, Taoyuan, Taiwan
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2019年 / 199卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A7292
引用
收藏
页数：1
相关论文
共 50 条
  • [31] PROGRAMMED DEATH-1 (PD-1), PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN TYPE 2 ENDOMETRIAL CANCER
    Gulec, U. Kucukgoz
    Bagir, E.
    Paydas, S.
    Seydaoglu, G.
    Guzel, A. B.
    Vardar, M. A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 220 - 220
  • [32] Programmed Cell Death Ligand 1 (PD-L1) Expression in Stage II and III Lung Adenocarcinomas
    Uruga, Hironori
    Fujii, Takeshi
    Moriguchi, Shuhei
    Takahashi, Yui
    Ogawa, Kazumasa
    Murase, Ryoko
    Mochizuki, Sayaka
    Hanada, Shigeo
    Takaya, Hisashi
    Miyamoto, Atsushi
    Morokawa, Nasa
    Fujimori, Sakashi
    Kono, Tadasu
    Kishi, Kazuma
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S987 - S988
  • [33] Assessment of programmed death-ligand 1 (PD-L1) expression in different breast tumor subtypes
    Sobral-Leite, M.
    de Vijver, K. Van
    Kersten, K.
    Peters, D.
    Kok, M.
    Broeks, A.
    De Visser, K. E.
    Schmidt, M. K.
    EUROPEAN JOURNAL OF CANCER, 2016, 57 : S128 - S128
  • [34] Programmed Cell Death-Ligand 1 (PD-L1) Immunohistochemical Expression in Equine Melanocytic Tumors
    Pimenta, Jose
    Prada, Justina
    Pires, Isabel
    Cotovio, Mario
    ANIMALS, 2024, 14 (01):
  • [35] Expression and prognostic significance of programmed death-ligand 1 (PD-L1) in Merkel cell carcinoma
    Richter, Igor
    Jirasek, Tomas
    Cermakova, Eva
    Bartos, Jiri
    Buchler, Tomas
    Dvorak, Josef
    JOURNAL OF BUON, 2019, 24 (05): : 2155 - 2160
  • [36] Programmed death-ligand 1 (PD-L1) expression in small cell carcinoma of bladder.
    Sanguino, Angela
    Samiei, Arash
    Pasricha, Gurleen
    Harinath, Lakshmi
    Miller, Ralph
    Lyne, John
    Silverman, Jan F.
    Mao, Shifeng
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [37] Co-Expression of Programmed Death Ligand-1 (PD-L1) and CD3 in Patients with EGFR Mutant NSCLC Treated with EGFR Tyrosine Kinase Inhibitors (TKI)
    Soot, Ross
    Kim, Hye Ryan
    Asuncion, Bernadette
    Fazreen, Zul
    Omar, Mohd Feroz Mohd
    Herrera, Macy C.
    Lim, Joey S.
    Chia, Grace V.
    Soong', Richie
    Cho, Byoung Chul
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S407 - S407
  • [38] Associations Histological Subtype of Lung Adenocarcinoma and Programmed Death Ligand 1 (PD-L1) Expression in Tumor Cells
    Cruz-Rico, G.
    Navarro, X. Popa
    Aviles-Salas, A.
    Flores-Velez, K. Y.
    Cardona, A.
    Ramirez-Tirado, L.
    Vergara, E.
    Barron, F.
    Cabrera-Miranda, L. A.
    Arrieta, O.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S730 - S730
  • [39] Genomic correlates of programmed cell death ligand 1 (PD-L1) expression in Chinese lung adenocarcinoma patients
    Kang Li
    Jun Liu
    Lin Wu
    Yajie Xiao
    Jia Li
    Haijian Du
    Zhikun Zhao
    Chao Sun
    Yongtian Zhao
    Jie Yang
    Dongfang Wu
    Zhuxiang Zhao
    Bolin Chen
    Cancer Cell International, 22
  • [40] Prognostic value of programmed death-ligand 1 (PD-L1) expression in patients with stage III colorectal cancer.
    Koganemaru, Shigehiro
    Inoshita, Naoko
    Miura, Yuji
    Fukui, Yudai
    Ozaki, Yukinori
    Tomizawa, Kenji
    Hanaoka, Yutaka
    Toda, Shigeo
    Suyama, Koichi
    Tanabe, Yuko
    Moriyama, Jin
    Fujii, Takeshi
    Matoba, Shuichiro
    Kuroyanagi, Hiroya
    Takano, Toshimi
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345